Compugen Ltd. is a biotechnology company that focuses on the discovery and development of novel therapeutic and diagnostic products through its computational discovery platforms. The company generates revenue by collaborating with pharmaceutical and biotech companies, leveraging its predictive discovery technologies to create development-stage assets that these partners can further advance through research, clinical trials, and commercialization.